Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)

NARecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2029

Conditions
Bladder Cancer
Interventions
RADIATION

hypo-IMRT

Twenty fractionation within 4 weeks are performed using hypofractionated intensity-modulated radiation therapy. As for the radiation dose, 2.8-3.2 Gy at a time, total dose 56-64 Gy, to the high-risk target volume, and 2-2.2 Gy at a time, and 40-44 Gy, respectively, to the low-risk target volume.

Trial Locations (1)

06351

RECRUITING

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER